Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

form 2

VIEWS: 4 PAGES: 3

									                         University of Illinois at Urbana-Champaign
                             Institutional Biosafety Committee
                               Research Project Registration




FORM 2: RECOMBINANT DNA RESEARCH



Complete the relevant section(s).

       Section A:   Non-viral Host – Vector Systems
       Section B:   Commercial Viral Host – Vector Systems
       Section C:   Non-commercial Viral Host – Vector Systems
       Section D:   Large Scale Fermentation

All research involving recombinant DNA, including all NIH exempt experiments, must be
registered with the IBC.




Section D: LARGE SCALE FERMENTATION
   1. Will Large-Scale (>10 liters) Fermentation be performed?

          Yes     No

   2. Where will the fermentation occur?

                 Onsite in my lab
                 Onsite in another lab
                     Provide building and room number:
                 Offsite – Commercial
                     Identify & describe:
                 Offsite – Other research institution
                     Identify & describe:




                                                                               Revised June 2009
FORM 2 Section D
RECOMBINANT DNA
Page 2 of 3



CLASSIFICATION

NIH requires that you identify the applicable section(s) of the NIH Guidelines that
applies to your rDNA research.
                                                                IBC – Institutional Biosafety Committee
Information regarding Risk Group Classifications                IRB – Institutional Review Board
can be found in the NIH Guidelines (1), Section II              NIH – National Institutes of Health
                                                                RAC – Recombinant DNA Advisory Committee
(2) and Appendix B (3).                                         OBA – Office of Biotechnology Activities (NIH)




   3. Which of the seven categories from the NIH Guidelines apply to the proposed project?
      (Select all that apply):

         Section III-A: Experiments that require IBC approval, RAC review and NIH director approval
                        before initiation (4)

         Section III-B: Experiments that require NIH/OBA and IBC approval before initiation (5)

         Section III-C: Experiments that require IBC and IRB approval and NIH/OBA registration
                        before initiation (6)

         Section III-D: Experiments that require IBC approval before initiation (7)

         Section III-E: Experiments that require IBC notification simultaneous with initiation (8)

         Section III-F: Exempt experiments (9)

         Appendix F: Containment conditions for cloning of genes coding for the biosynthesis of
                     molecule toxic for vertebrates(10)

         Appendix K: Physical containment for large scale uses of organisms containing recombinant
                     DNA molecules (11)




Active hyperlink references are available at the end of this form to assist you with
identification.

                    ACTIVE HYPERLINK REFERENCES
      1. NIH Guidelines for work involving recombinant DNA molecules;
         http://oba.od.nih.gov/oba/rac/guidelines_02/NIH_Guidelines_Apr_02.htm
      2. Section II: Safety Considerations
         http://oba.od.nih.gov/oba/rac/guidelines_02/NIH_Guidelines_Apr_02.htm#_Toc7261553
      3. Appendix B: Classification of human etiologic agents on the basis of hazard
         http://oba.od.nih.gov/oba/rac/guidelines_02/APPENDIX_B.htm
      4. Section III-A: Experiments that require IBC approval, RAC review and NIH director approval
         before initiation
         http://oba.od.nih.gov/oba/rac/guidelines_02/NIH_Guidelines_Apr_02.htm#_Toc7261560
      5. Section III-B: Experiments that require NIH/OBA and IBC approval before initiation
         http://oba.od.nih.gov/oba/rac/guidelines_02/NIH_Guidelines_Apr_02.htm#_Toc7261562

                                                                                            Revised June 2009
FORM 2 Section D
RECOMBINANT DNA
Page 3 of 3




      6. Section III-C: Experiments that require IBC and IRB approval and NIH/OBA registration
          before initiation
          http://oba.od.nih.gov/oba/rac/guidelines_02/NIH_Guidelines_Apr_02.htm#_Toc7261564
      7. Section III-D: Experiments that require IBC approval before initiation
          http://oba.od.nih.gov/oba/rac/guidelines_02/NIH_Guidelines_Apr_02.htm#_Toc7261566
      8. Section III-E: Experiments that require IBC notification simultaneous with initiation
          http://oba.od.nih.gov/oba/rac/guidelines_02/NIH_Guidelines_Apr_02.htm#_Toc7261573
      9. Section III-F: Exempt experiments
          http://oba.od.nih.gov/oba/rac/guidelines_02/NIH_Guidelines_Apr_02.htm#_Toc7261577
      10. Appendix F: Containment conditions for cloning of genes coding for the biosynthesis of
          molecules toxic for vertebrates
          http://oba.od.nih.gov/oba/rac/guidelines_02/Appendix_F.htm
      11. Appendix K: Physical containment for large scale uses of organisms containing
          recombinant DNA molecules
          http://oba.od.nih.gov/oba/rac/guidelines_02/Appendix_K.htm




                                                                                Revised June 2009

								
To top